Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An abbreviation of the WAIS for clinical use.

Literature DB >> 14497487

An abbreviation of the WAIS for clinical use.

P SATZ, S MOGEL.

Abstract

Keywords: INTELLIGENCE TESTS

Mesh：
Humans
Intelligence Tests

Year: 1962 PMID： 14497487 DOI： 10.1002/1097-4679(196201)18:1<77::aid-jclp2270180124>3.0.co;2-r

Source DB: PubMed Journal: J Clin Psychol ISSN： 0021-9762

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Use it or lose it? SES mitigates age-related decline in a recency/recognition task.

Authors: Daniela Czernochowski; Monica Fabiani; David Friedman
Journal: Neurobiol Aging Date: 2007-02-05 Impact factor: 4.673

2. The application of short forms of the Wechsler Intelligence scales in adults and children with high functioning autism.

Authors: Nancy J Minshew; Catherine A Turner; Gerald Goldstein
Journal: J Autism Dev Disord Date: 2005-02

3. Levodopa's awakening effect on patients with Parkinsonism.

Authors: G G Marsh; C M Markham; R Ansel
Journal: J Neurol Neurosurg Psychiatry Date: 1971-06 Impact factor: 10.154

4. Neuropsychological syndrome in a patient with episodic howling and violent motor behaviour.

Authors: G G Marsh
Journal: J Neurol Neurosurg Psychiatry Date: 1978-04 Impact factor: 10.154

5. Response-specific slowing in older age revealed through differential stimulus and response effects on P300 latency and reaction time.

Authors: Theodore R Bashore; Scott A Wylie; K Richard Ridderinkhof; Jacques M Martinerie
Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2013-11-06

An abbreviation of the WAIS for clinical use.

1. Use it or lose it? SES mitigates age-related decline in a recency/recognition task.

2. The application of short forms of the Wechsler Intelligence scales in adults and children with high functioning autism.

3. Levodopa's awakening effect on patients with Parkinsonism.

4. Neuropsychological syndrome in a patient with episodic howling and violent motor behaviour.

5. Response-specific slowing in older age revealed through differential stimulus and response effects on P300 latency and reaction time.

6. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort.

7. Does levodopa alter depression and psychopathology in Parkinsonism patients?

8. Word reading threshold and mild cognitive impairment: a validation study.

9. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease.

10. Further evidence of a cumulative effect of social disadvantage on risk of psychosis.